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Tendons are prominent members of the family of fibrous connective tissues (FCTs), which collectively are
themost abundant tissues in vertebrates and have crucial roles in transmittingmechanical force and linking
organs. Tendon diseases are among the most common arthropathy disorders; thus knowledge of tendon
gene regulation is essential for a complete understanding of FCT biology. Here we show autonomous
circadian rhythms in mouse tendon and primary human tenocytes, controlled by an intrinsic molecular
circadian clock. Time-series microarrays identified the first circadian transcriptome of murine tendon,
revealing that 4.6% of the transcripts (745 genes) are expressed in a circadian manner. One of these genes
was Grem2, which oscillated in antiphase to BMP signaling. Moreover, recombinant human Gremlin-2
blocked BMP2-induced phosphorylation of Smad1/5 and osteogenic differentiation of human tenocytes in
vitro. We observed dampened Grem2 expression, deregulated BMP signaling, and spontaneously calcifying
tendons in young CLOCKD19 arrhythmic mice and aged wild-type mice. Thus, disruption of circadian
control, through mutations or aging, of Grem2/BMP signaling becomes a new focus for the study of calcific
tendinopathy, which affects 1-in-5 people over the age of 50 years.
D
iseases and injury to tendons are a major biomedical problem. Rotator cuff disease, repetitive motion
injuries, complications following iatrogenic injury, and tendon rupture, collectively affect 1-in-3 people
over the age of 40 years and incur a significant sociological and economic burden (see1,2 and references
therein). Calcium deposits in the mid-substance of the tendon are common in rotator cuff tendons,
Supraspinatus, Achilles and patellar tendons resulting in calcific tendinopathy (CT), which has a prevalence of
between 2.7% and 22% depending on age and gender (reviewed by3–7). Thus, tendinopathies are the most
common of the arthropathy disorders. However, the pathophysiology is not always associated with overuse,
indicative of an underlying defect in tissue homeostasis as a result of age. An under-researched aspect is the
dramatic differences in physiological activity of tendons during a 24-hour cycle of being asleep and awake, and if
these differences are influenced by aging and gene expression changes.
The circadian clock coordinates the 24-hourly rhythms in biochemical and behavioral parameters that help
prepare an organism for anticipated changes in its environment. In addition to the central pacemaker in the
suprachiasmatic nuclei (SCN), many peripheral organs contain autonomous peripheral clocks8,9. Mammalian
circadian clocks rely on the transcriptional/translational feedback loops consisting of the transcriptional activator
complex CLOCK and BMAL1 (bone andmuscle ARNT-like 1), and repressor complex PERIOD1/2 and CRY1/2.
PERs/CRYs periodically inhibit the CLOCK/BMAL1-mediated transactivation of the Pers and Crys through E-
box elements in their promoters. The core oscillator then drives rhythmic clock-controlled genes through
regulatory elements in their promoters (e.g. E-box, D-box, and ROREs).
Importantly, mice with a deletion of Bmal1 show age-related and non-inflammatory arthropathy, including
ectopic tendon calcification10. It was unknown if the tendon phenotype was the result of Bmal1 gene-specific
effects or to disruptions to themolecular clock, and if the latter, if tendon contains a functional clock that controls
tissue homeostasis. Here, we show for the first time the presence of self-sustained circadian clocks in mouse
tendon and human tenocytes, and, the circadian clock controls BMP signaling. The results indicate that tendon
clocks control 4.6% of local transcripts including Grem2, which we show is an antagonist of BMP signaling and
inhibits calcification of primary human tenocytes in culture. Disruption of the circadian rhythms in the arrhyth-
mic CLOCKD19 mice11 is associated with aberrant Grem2 expression and BMP signaling, calcific pathology and
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mechanically weak tendons. Finally, we show that aged wild-type
mice exhibit a dampened and delayed tendon circadian rhythm
associated with profound calcification.
Results
Autonomous circadian rhythm in tendon. To investigate if tendon
has an intrinsic clock we examined Achilles and tail tendons from
PER2::Luc reporter mice12 and used real-time bioluminescence
microscopy and a photomultiplier tube (PMT) to record light
emission. This revealed robust circadian rhythms of PER2::Luc
activity, with periods of 23.73 6 0.26 hr and 23.23 6 0.06 hr in
Achilles and tail tendons, respectively, indicating that there is a
circadian clock in Achilles and tail tendon (Figure 1A and B, and
Supplementary video). As expected, the rhythm dampened over time
in culture but was effectively reinstated after a single treatment with
dexamethasone, a known synchronizing agent for peripheral clocks.
We next examined the circadian rhythm of Achilles and
tail tendons from the CLOCKD19 x PER2::Luc crosses. The
CLOCKD19 mice harbor a deletion in exon 19 of the CLOCK
gene producing a dominant negative mutant protein11. The results
confirmed that CLOCKD19 tendons are arrhythmic (Figure 1C).
We also established that tendon cells isolated from wild type but
not CLOCKD19 tail tendons have an autonomous circadian
rhythm (Figure 1D). To extend these studies to human tendon
cells, primary human tenocytes were transduced with lentivirus
carrying Bmal1- or Per2-promoter-driven luciferase reporters.
Both reporters showed circadian oscillation in anti-phase to one
another (Figure 1E).
Figure 1 | Tendon tissues and cells have an autonomous circadian rhythm. (A) Bioluminescence microscopy of dissected Achilles tendon from
PER2::Luc reporter mouse imaged in the presence of 100 nM dexamethasone. Image of the dissected Achilles tendon under phase contrast microscopy is
shown, where dotted red lines outline the tendon shaft. (B–D) PMT recordings of endogenous circadian rhythms and re-initiation of the rhythms with
100 nM dexamethasone (arrow) in dissected Achilles and tail tendons from PER2::Lucmice (B); compared with tendons fromCLOCKD19mice bred on
a PER2::Luc background (C); and in cultured tail tendon cells isolated from wild type and CLOCKD19 x PER2::Luc mice (D). (E) PMT recordings of
Per2::Luc and Bmal1::Luc reporters expressed in primary human tendon cells. Representative readings from one preparation of cells are shown. Arrow
indicates re-initiation of rhythm with 100 nM dexamethasone.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 4 : 5183 | DOI: 10.1038/srep05183 2
The circadian transcriptome in tendon. Circadian transcriptome
studies in muscle, liver and cartilage have demonstrated very low
numbers of overlapping rhythmic genes, highlighting the tissue-
specific functions of the peripheral circadian clocks (for discussion
see9). To gain further insights into the functions of the tendon clock,
we performed a time-series microarray to identify the circadianly-
regulated genes. Female C57BL/6 mice were kept in constant dark-
ness for 39 hr to reveal genes driven by the endogenous circadian
clock rather than by light-related cues. Tail tendon was taken at 4-hr
intervals during 48 hr. In total, 16,000 genes (represented by 29,000
probes) were classified as expressed. To identify circadian tran-
scripts, we used two well-recognized algorithms based on different
statistical models as described previously9. CircWave Batch revealed
,1000 probes oscillating with a period of ,24 hr (Figure 2A and
Figure 2 | Circadian transcriptome in tendon. (A)Heatmap depicting the expression level of the 745 circadian genes (4.6%of the tendon transcriptome)
identified by Circwave Batch and JTKCycle. Genes are organized according to timing of peak expression in circadian time (CT). DD 5 hours in
dark/dark cycle. Grey bars represent subjective day; black bars represent subjective night. (B) Specificity of tendon clock genes. Venn diagram comparing
the number of circadian genes of tendon, cartilage9 and skeletal muscle8. The total number of genes identified as circadian in each tissue is represented in
brackets; areas of overlap indicate common genes. (C) qPCR validation of time-dependent expression of clock genes, Bmal1, Per2, and Nr1d1 (REV-
ERBa) in mouse tendons. qPCR values (n 5 6 for tail tendons; n 5 4 for Achilles tendons) normalized toGAPDH. Microarray data of tail tendon (n 5 2)
was plotted for comparison. Grey shadow indicates subjective night phase. (D) Time-dependent expression of clock genes, Bmal1, Per2 andNr1d1 (REV-
ERBa) in primary human tendon cells (n 5 3). Cells were synchronized with 50% horse serum and gene expression was analyzed by qPCR. qPCR values
normalized to GAPDH. Mean data from three preparations of cells shown. Error bars indicate SEM.
www.nature.com/scientificreports
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Figure S1, q , 0.003). The JTKcycle algorithm identified 1,500
rhythmic probes with 20–28 hr period (q , 0.1). To be stringent,
we considered only those genes identified by both methods to be
circadianly regulated. From these analyses we identified 745 genes
(4.6% of genes expressed in tendon) with rhythmic expression and a
period of ,24 hr (Figure 2A). The uniqueness of the tendon circa-
dian transcriptome is shown schematically in Figure 2B in that only
14 genes are common between previously published circadian-
regulated genes in cartilage and skeletal muscle8,9. Among the 14
common genes were the core clock components Bmal1, Per2 and
Nr1d1, whose circadian expression rhythms were validated by qPCR
in mouse Achilles and tail tendon (Figure 2C). Using a Gaussian
process model with a Bayesian approach9, rhythmic tendon genes
were clustered into 9 distinct clusters according to their inferred
periodic functions (Figure S2, Supplementary Table 2). Most genes
peaked during late night and early day (Figure S3). In addition,
expression of endogenous core clock genes, Bmal1, Per2 and
Nr1d1 were rhythmically expressed in primary human tenocytes
(Figure 2D). Thus, mouse and human tendon cells exhibit a cell
autonomous circadian molecular oscillator.
Grem2 as a clock controlled gene in tendon. One of the rhythmic
genes in tendon was Grem2, with expression peaks in the beginning
of day and is down-regulated at night (Figure 3A and B). The
Xenopus Gremlin is a secreted protein that can block BMP sig-
naling by binding BMPs, thereby preventing receptor activation
and phosphorylation of Smad1/513 (reviewed by14 and discussed in
more detail below). Therefore, we predicted that the mammalian
Grem2 might have a similar role in antagonizing BMP signaling.
We used western blot analysis to assess levels of phosphorylated
Smads in temporally-collected tail-tendon proteins (Figure 3C).
Phosphorylation of Smad1/5 was observed at all 6 time points
across one circadian cycle but was noticeably less abundant at
CT3, CT7 and CT11 and more abundant at CT15, CT19 and
CT23. The total amount of Smad1, Smad5, Smad2 and phosphory-
lated Smad2 (a known target of TGFb) did not appear to vary. Target
genes of BMP signaling include inhibitor of differentiation 1 (Id1),
Id2 and Id3 and Bmp2k (BMP2-inducible kinase)15,16. The micro-
array expression profiles of Id1, Id3 and Bmp2k were lower in the
day phase and higher in the night phase (Figure 3D). Thus, the data
support the hypothesis that BMP signaling in tendon is ‘‘gated’’ by
the circadian clock, with an opposing pattern to the rhythmic
expression of Grem2.
Gremlin-2 inhibits phosphorylation of Smad1/5 and calcium
deposition. To determine if Gremlin-2 is capable of inhibiting
BMP signaling we used an in vitro osteogenic differentiation model
for human tenocytes. Addition of rhBMP2 to primary human tendon
Figure 3 | Circadian control of Grem2 expression and BMP signaling in mouse tendon. (A) Time-dependent expression ofGrem2 from the microarray
analysis of tail tendon (n 5 2) and qPCR validations in tail (n 5 6) and Achilles tendons (n 5 4). (B) Time-dependent expression of Grem2 in primary
human tendon cells. Representative data from one preparation of cells shown. Cells were synchronized with 50% horse serum and gene expression was
analyzed by qPCR. (C)Wild typemice were kept in DD for 36 hr to allow endogenous circadian rhythmof gene expression. Protein was purified from tail
tendons at 4-hr intervals and phosphorylation of Smad1/5 were analyzed by western blotting. Levels of GAPDH protein served as a loading control.
Full-length western blots are shown in Supplementary Figure S4. (D) Endogenous expression pattern of BMP signaling target genes, Id1, Id3 and Bmp2k,
in tail tendon over 44 hr detected by time-series microarray (n 5 2). Error bars indicate SEM. Grey shadow indicates subjective night phase.
www.nature.com/scientificreports
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cells activated the phosphorylation of Smad1/5, which was reduced
by pre-incubation with rhGremlin-2 (Figure 4A). Next, human
tendon cells cultured in an osteogenic medium for 14 days stained
bright red by Alizarin red, indicative of calcium deposition
(Figure 4B). However, only low-level calcium deposition was
observed in cells co-incubated with rhGremlin-2. Together, these
data show that Gremlin-2 inhibits BMP signaling and calcium
deposition in human tenocytes.
Aberrant BMP signaling and ectopic calcification in Achilles
tendon of CLOCKD19 mice. The circadian control of Grem2 and
BMP activity prompted us to hypothesize that the CLOCKD19
mouse will have aberrant BMP signaling, predisposing the tendons
to calcification. To test this, we first compared the expression of
Grem2 in CLOCKD19 with wild type tail tendons at two time
points corresponding to the peak and trough expression of Grem2.
Consistent with the loss of circadian rhythms inCLOCKD19 tendons
(Figure 1C), we observed a lack of time-dependent expression for
Grem2 (Figure 5A). Importantly, at the peak expression time of CT7
in wild type tendons, Grem2 expression in CLOCKD19 tendon was
significantly low. The low level of Grem2 expression was associated
with an aberrant pattern of phosphorylated Smad1/5 (Figure 5B).
Noteworthy, low level BMP signaling seen in wild-type tendon at
CT7 was replaced by elevated BMP signaling in the CLOCKD19
tendons, suggesting an inhibitor function of the clock on BMP
signaling. Alizarin Red staining of Achilles tendon showed the
presence of calcification in tendons of CLOCKD19 mice but not in
young age-matched wild type mice (Figure 5C).
Aberrant clock in aged tendons is associated with ectopic
calcification. To test if the tendon clock changes with ageing, we
compared PER2::Luc rhythms in tendon fromold (22–24month old)
and young adult (2–3 month old) mice (Fig 6A). There was a
significant 40% reduction in the oscillation amplitude of PER2::Luc
rhythms in aged tendon and the circadian phase was delayed by
,6 hr (Figure 6B–D). Comparison of the mRNA levels of core
clock genes in young and old tendon showed significant dam-
pening in the time-of-day dependent expression of Bmal1 and
Per2 and reduced levels of Nr1d1 (Figure 6E). Importantly, in
parallel to the clock gene changes, the rhythmic expression of
Figure 4 | Gremlin-2 inhibits BMP signaling and calcium deposition by
human tendon cells. (A) Primary human tendon cells were treated with
recombinant human BMP2 in the presence or absence of recombinant
human Gremlin-2. Phosphorylation of Smad1/5 was examined by western
blotting (n 5 3). Western blot analysis of GAPDH protein served as a
loading control. Full-length western blots are shown in Supplementary
Figure S5. (B) Primary human tendon cells cultured in osteogenicmedium
in the presence or absence of 400 ng/ml recombinant human Gremlin-2
for 14 days were stained with Alizarin red (n 5 3). Bars 5 200 mm.
Figure 5 | Tendons from CLOCKD19 mice exhibit ectopic calcification.
(A) Expression of Grem2 in tail tendons of CLOCKD19 mice compared
with wild type tendons at CT7 (peak expression) and CT19 (nadir
expression) (n 5 3). qPCR values normalized to GAPDH. *p, 0.05, one-
way ANOVA. Error bars indicate the SEM. (B) Protein was purified from
CLOCKD19 tail tendons at CT7 and CT19 and phosphorylation of Smad1/
5 were analyzed by western blotting (n 5 2). Western blot analysis of
GAPDH protein served as a loading control. (C) Longitudinal sections of
Achilles tendon from 18 week-old wild type and CLOCKD19mice stained
with Alizarin red. b 5 attachment of tendon to bone, m 5 attachment of
tendon to muscle. Bars 5 500 mm.
www.nature.com/scientificreports
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Grem2 seen in young tendon was severely dampened in the old
tendon. Finally, the aged wild-type mice (22–24 month old)
developed calcific deposits in their Achilles tendons (Figure 6F).
Discussion
We have identified cell-autonomous oscillations of clock genes
in murine and human tenocytes and shown that the circadian
clock is a master regulator of BMP signaling. These results provide
a basis for exploring the links between tendon clocks, ageing and
tendinopathies.
Circadian clock disruptions have been linked to various patholo-
gies and diseases, including defects in the musculoskeletal system.
For instance, bone volume is significantly increased in the Per2
mutant and Cry2 knockout mice, caused by defects in osteoblasts
and osteoclasts, respectively17. Furthermore, shorter bone length was
reported in the Bmal1 knockout mouse because of defects in chon-
drocyte differentiation in the growth plate18. Moreover, maximal
muscle force was reduced (by 30%) in the Bmal1-null and CLOCK
mutant mice19. Consistently, by comparing the tendon circadian
transcriptome to that of the cartilage9 and muscle8, we found that
Figure 6 | Ectopic calcification in aged tendons correlates with disrupted circadian rhythm and altered Grem2 expression. (A) Representative PMT
recordings (raw and normalized) of ex vivo tail tendons from young (2–3 months) and old (22–24 months) PER2::Luc mice (n 5 3). Comparison of
(B) circadian phase, (C) amplitude and (D) period between young and aged groups (n 5 4). (E) Expression of clock genes, Bmal1, Per2 and Nr1d1
(REV-ERBa), and Grem2 in tail tendon of young (2–3 months) and old (22–24 months) at ZT3 and ZT15 (n 5 2). qPCR values normalized to GAPDH.
*p , 0.05, **p , 0.01, unpaired t-tests. Error bars indicate the SEM. (F) Alizarin red staining of longitudinal sections of Achilles tendon from
young (2–3 months) and aged (22–24 months) wild type mice. Bars 5 500 mm.
www.nature.com/scientificreports
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these tissues had few rhythmic genes in common. In fact, the major-
ity of the common rhythmic genes encoded components of circadian
clocks.
Interestingly, the initial phenotypic characterization of the Mop3
(Bmal1) null mouse reported ectopic calcification in tendons and
ligaments, among other signs of non-inflammatory arthropathy10.
The underlying mechanisms for the calcified tendonopathies have
never been addressed. Our results showing calcification in the
CLOCKD19 mouse tendons, support a hypothesis that the CLOCK/
BMAL1 complex regulates key signaling pathways that inhibit
ectopic calcification in normal rhythmic mice. Thus, when the cir-
cadian rhythm is disrupted, the tendons are predisposed to
calcification.
BMPs are the largest class of signaling ligands in the TGFb super-
family and regulate a wide variety of processes during embryo pat-
terning, skeletal and non-skeletal development, differentiation of cell
fate, and have additional roles in cancer and tumor progression
(reviewed by20). The basic signaling mechanism is the same for all
TGFb superfamily members and is initiated when ligand dimers
engage with type I and type II serine/threonine kinase receptors. In
the activated receptor complex, the type II receptor phosphorylates
the type I receptor which provides a binding site for the receptor-
regulated SMADs (R-SMADs). The plethora of normal biological
processes triggered by BMP signaling, and the involvement of the
pathway in pathological conditions including cancer, is partly
explained by the large number of BMP ligands (,20 in number),
the choice of type I and type II receptors (12 in total) for ligand
engagement, and the availability of SMAD dependent and SMAD-
independent signal transduction. With such multiple opportunities
for pathway activation, the blockade of BMP ligand-receptor engage-
ment by extracellular antagonists is a crucial on-off switch of the
signaling pathway. Thus, the circadian clock could be a super-regu-
lator of BMP signaling by regulating the expression of Grem2.
Gremlins are small, single domain proteins that contain a
cysteine-rich fold that occurs in members of the DAN/Cerberus
family of secreted BMP antagonists21–25. Gremlin-1 prevents binding
of BMP receptor binding but does not affect the activity of other
members of the TGFb superfamily13. Gremlin-2 (also known as
Protein Related to Dan and Cerberus, PRDC) is the second member
of the Gremlin family and can inhibit ligand signaling by BMP2 and
BMP4 but has minimal effects on GDF-9, activin and TGFb signal-
ing26. Previous studies have shown that Grem2 restricts BMP signal-
ing to the ventral arches and thereby promotes dorsal and
intermediate skeletal fates27, is necessary for cardiac laterality and
atrial differentiation28, and can promote the differentiation of stem
cells to cardiomyocytes29. However, a role for Grem2 in tendon
homeostasis and calcification had not been previously described.
BMP signaling has been shown to drive osteogenic differentiation
of tendon-derived stem cells30. Furthermore, BMP2 and BMP7 can
be detected in the subacromial bursa of patients with chronic rotator
cuff degeneration at levels sufficient to induce osteogenic differenti-
ation of mouse myoblast-derived C2C12 cells31.
Analysis of our microarray data showed that Grem2 (but not
Bmp2, Bmp4 and Bmp7) was rhythmically expressed in tendon.
The rhythmic expression of Grem2 was validated in mouse
Achilles and tail tendon and primary human tendon cells. In further
experiments we showed that at the peak expression time of CT7,
Grem2 expression in CLOCKD19 mutant tail and Achilles tendons
was significantly lower than in wild-type tendons, thus indicating a
role of the molecular circadian clock in regulating Grem2 expression
in tendon.We also showed that BMP-signaling target genes (Id1, Id3
and Bmp2k) are rhythmic, indicating circadian activity of the BMP
signaling. A mechanistic link between Gremlin-2 and tendon cal-
cification was evident when Gremlin-2 was capable of inhibiting
BMP-induced calcification of human tenocytes in culture, revealing
Gremlin-2 as a novel potent antagonist of BMP signaling in tendon.
Consistent with the inhibitory role of Gremlin-2, we observed a
profound day/night difference in the Smad1/5 phosphorylation
opposing the levels of Grem2 expression. Therefore, the circadian
control of Grem2 is likely to be involved in ‘‘gating’’ the BMP signal-
ing pathway in a rhythmic manner.
It is well established that systemic circadian rhythms dampen with
aging as shown by body temperature cycles and hormones (see32 and
references therein). Likewise, we showed that tendon rhythms with
altered phase and reduced oscillation amplitude are a feature of aging
mice. The delayed phase implies that there is an internal desyn-
chrony between tendon clocks and the central brain clock, which
might disrupt the temporal coordination of the tendon rhythmic
genes. Such desynchrony in gene expression is exacerbated by the
reduced amplitude, leading to compromised tissue homeostasis and
increased risk of pathology. As age is a risk factor for calcific tendi-
nopathies in elderly humans, we envisage a scenario inwhich chronic
circadian misalignment/disruption (e.g. during aging) predisposes
tendon tissue to calcific changes. Future studies in humans and the
use of conditional mutant mouse models may reveal more informa-
tion about the tendon clock as an important regulator of tissue
physiology and pathology.
Methods
Animals. All animal work was approved by The University of Manchester Breeding
and Supply Unit and was in accordance with the 1986 Home Office Animal
Procedures Act (UK), and following local ethical review.
Tendon Explant Cultures and Bioluminescence Recording. Tendon cultures from
PER2::Lucmice were prepared by dissecting out theAchilles and tail tendons. Tendon
explants were cultured on 0.4 mmcell culture inserts (Millipore) and bioluminescence
was recorded in real-time using as previously described33. Dexamethasone (100 nM)
was added to the recording media to re-initiate circadian rhythms. Baseline
subtraction, period, phase and amplitude calculation was carried out as previously
described9. Cultures were also visualized using a self-contained Luminoview LV200
microscope (Olympus) and recorded using a cooledHamamatsu ImageEMC9100-13
EM-CCD camera. Images were taken every hour for 4 days, and combined in ImageJ.
Time Series Microarrays and Quantitative PCR. The circadian transcriptome
studies in tendon were performed as described before9. Tail tendons were collected
every 4 hr commencing at circadian time CT3 (3 hr into the light phase), for 48 hr.
Tissues (6 samples per time point) were snap frozen in liquid nitrogen. Two samples
per time point were used formicroarray; the remainder was used for qPCR validation.
RNA extractions were carried out using TRIzol reagent (Invitrogen) according to
manufacturer’s protocol. Mouse430_2 Affymetrix GeneChips were run according to
manufacturers’ instructions. Raw data were deposited in Array Express (accession
number pending). CircWave v5 (by Dr. Roelof Hut, cut-off point of q , 0.003) and
JTK-Cycle34 (q-value of 0.1) were used to identify circadian transcripts as described
previously9. Local false discovery rate was calculated using an R package ‘fdrtool’35. To
be stringent, genes identified using both methods are counted as positive. To model
the data for clustering, we used a Gaussian process model9. Validation of time-series
arrays and gene expression analyses was examined by qPCR (for primers see
Supplementary Table 1) as described previously36.
Primary Mouse and Human Tenocytes Culture. Cells from tail tendons were
released by treatment with 1000 U/ml bacterial collagenase type 4 (Lorne
Laboratories) in 0.25% (wt/vol) trypsin (Invitrogen). Cells were grown at 37oC until
90–100% confluent prior to synchronization and PMT recording. Primary human
tenocytes were obtained as described previously37. Cells from three preparations were
used in the experiments described in this study. For time course experiments,
confluent cells were synchronized with DMEM:F12 containing 50% (v/v) horse
serum (Invitrogen), L-G and P/S for 2 hr at 37oC. RNA was isolated after 24 hr, at 4-
hr intervals for 20 hr. For treatment with recombinant human BMP2 (PHC7145,
Invitrogen) and recombinant human Gremlin-2 (SRP4657, Sigma), 90–100%
confluent cells were washed with PBS and incubated with serum-free media for 1 hr
at 37oC. Then, cells were treated with BMP2 that had been pre-incubated for 1 hr at
4oC with Gremlin-2 in serum-free medium. Protein was isolated after 24 hr and
analyzed by western blotting.
Lentiviral Transduction. Lentiviral transduction of primary human tenocytes was
performed using methods previously described9.
Protein Extraction andWestern Blotting. Proteins from tail tendons were extracted
from frozen tissue with ice-cold cell lysis buffer (20 mM Tris/HCl pH 7.6, 150 mM
NaCl, 1 mM ethylene diamine tetra-acetic acid (EDTA), 1% (v/v) Igepal CA-630,
50 mM sodium fluoride) containing complete, mini EDTA-free protease inhibitor
cocktail and PhosSTOP phosphatase inhibitor cocktail (Roche). Lysates were cleared
www.nature.com/scientificreports
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by centrifugation at 10 000 3 g, at 4oC. Commercially available antibodies used to
detect phospho-Smad1/5 (#9516), Smad1 (#6933), Smad5 (#9517), phospho-Smad2
(#3108) and Smad2 (#3103) were purchased from Cell Signaling Technologies.
GAPDH was detected using a monoclonal antibody from Sigma (G8795).
Calcium Deposition Assay and Alizarin Red Staining. Achilles tendons were fixed
in 2% (w/v) PFA in PBS for 20 minutes, wax processed. 5–6 mm sections were de-
waxed before staining. Calcium deposition in primary human tenocytes was induced
by culturing cells in Osteogenic Medium (Lonza) according to the manufacturer’s
protocol. After 14 days, cells were fixed with 2% (w/v) PFA in PBS for 20 minutes.
Fixed cells or tissue sections were washed with distilled water and stained with 2% (w/
v) Alizarin Red S, pH 4.2 for 10 min. Washed plates or sections were air-dried and
imaged using a Pannoramic slide scanner and Pannoramic Viewer software
(3DHISTECH).
Statistical Analyses. Mean and standard error of the mean were calculated for each
data set from at least three biological replicates (indicated by the n in figures). Data
was evaluated using two sample t-tests with GraphPad Prism (GraphPad Software).
Differences were considered significant at the values of p, 0.05 (*), p, 0.01 (**) or p
, 0.0001 (***).
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